GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Cyclically Adjusted Book per Share

Lyka Labs (BOM:500259) Cyclically Adjusted Book per Share : ₹19.70 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lyka Labs's adjusted book value per share for the three months ended in Mar. 2024 was ₹20.597. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹19.70 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lyka Labs's average Cyclically Adjusted Book Growth Rate was -36.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-10), Lyka Labs's current stock price is ₹106.20. Lyka Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹19.70. Lyka Labs's Cyclically Adjusted PB Ratio of today is 5.39.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lyka Labs was 7.24. The lowest was 2.98. And the median was 5.65.


Lyka Labs Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lyka Labs's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Cyclically Adjusted Book per Share Chart

Lyka Labs Annual Data
Trend Jun14 Jun15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 31.18 19.70

Lyka Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.18 - 19.45 - 19.70

Competitive Comparison of Lyka Labs's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Lyka Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lyka Labs's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Cyclically Adjusted PB Ratio falls into.



Lyka Labs Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lyka Labs's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=20.597/153.0345*153.0345
=20.597

Current CPI (Mar. 2024) = 153.0345.

Lyka Labs Quarterly Data

Book Value per Share CPI Adj_Book
201209 0.000 82.244 0.000
201212 0.000 83.774 0.000
201303 31.025 85.687 55.410
201306 0.000 88.365 0.000
201309 28.019 91.042 47.098
201312 0.000 91.425 0.000
201406 24.427 94.103 39.724
201412 0.000 96.780 0.000
201506 19.954 99.841 30.585
201512 25.933 102.901 38.568
201603 0.000 102.518 0.000
201606 0.000 105.961 0.000
201609 18.425 105.961 26.610
201612 0.000 105.196 0.000
201703 17.788 105.196 25.877
201803 17.579 109.786 24.504
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 15.286 118.202 19.791
201906 0.000 120.880 0.000
201909 13.944 123.175 17.324
201912 0.000 126.235 0.000
202003 -5.000 124.705 -6.136
202006 0.000 127.000 0.000
202009 -8.669 130.118 -10.196
202012 0.000 130.889 0.000
202103 -8.992 131.771 -10.443
202106 0.000 134.084 0.000
202109 7.689 135.847 8.662
202112 0.000 138.161 0.000
202203 4.649 138.822 5.125
202206 0.000 142.347 0.000
202209 4.701 144.661 4.973
202212 0.000 145.763 0.000
202303 14.806 146.865 15.428
202306 0.000 150.280 0.000
202309 20.616 151.492 20.826
202312 0.000 152.924 0.000
202403 20.597 153.035 20.597

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lyka Labs  (BOM:500259) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lyka Labs's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=106.20/19.7
=5.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lyka Labs was 7.24. The lowest was 2.98. And the median was 5.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lyka Labs Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lyka Labs (BOM:500259) Business Description

Industry
Traded in Other Exchanges
Address
30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines